415 Capital — Full Portfolio
33 tracked investments · listed companies and verified rows first
Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock.
HardwareHealthtechMedical DevicesCampbell, US
Nitin Salunke(President & CEO)Jean Orth(Executive Officer)Mariam Maghribi(Executive Officer, Director)
BoardCasey Gordon(Director)Christopher Shen(Director)Bihua Chen(Director)
Co-investorsAmed VenturesThe Capital PartnershipNovo HoldingsUnorthodox Ventures
Boston Heart Diagnostics provides cardiovascular diagnostic testing and lifestyle management programs, serving healthcare providers and their patients.
Digital HealthHealthtechMedical Devices
Co-investorsKeiretsu ForumSilversmith Capital Partners
PartnerFrederik Groenewegen· led
Co-investorsAdvent Life Sciences
HealthtechSanta Rosa, US
James Eadie(Director)Tony Fields(Executive Officer)Fred Khosravi(Director)Henry A. Plain(Director)Leo Nelson Hopkins(Director)
BoardAzin Parhizgar(Executive Officer, Director)
Co-investorsLightstone Ventures
Co-investorsSofinnova Partners
PartnerFrederik Groenewegen· led
Distalmotion develops DEXTER, a surgical robotics system for minimally invasive procedures such as hernia repair, cholecystectomy, and hysterectomy, used by surgeons and clinical teams.
HealthtechMedical DevicesRoboticsLausanne, CH
PartnerFrederik Groenewegen· led
Co-investors4see VenturesPrivilège VenturesZühlke Ventures
HealthtechMalvern, US
Greg A. Walters(Executive Officer, Director)GREG A. WALTERS(Executive Officer, Director)
BoardPieter Wolters(Director)PIETER WOLTERS(Director)Ian Freelance(Director)Joseph Kaufmann(Director)
San Diego, US
Marcelo Lima(Executive Officer, Director, Promoter)Brian Blischak(Executive Officer)Paul Meadows(Executive Officer)
BoardSpencer Segura(Director, Promoter)James Lenehan(Director)Richard Lawrence(Director)
BiotechHealthtechWayne, US
Robert Giasolli(Executive Officer)Carol Burns(Executive Officer)Marc Penna(Executive Officer)Monica Klos(Executive Officer)Dennis Wahr(Director)P. Sherrill Neff(Director)
Co-investorsH.I.G. CapitalH.I.G. HealthBridge PartnersRunway Growth CapitalH.I.G. BioHealth PartnersNew Enterprise Associates (NEA)Vensana Capital
Laza Medical develops an AI- and robotics-powered ultrasound imaging system for structural heart, electrophysiology, and diagnostic cardiac procedures, combining real-time 3D heart modeling, procedural guidance, and robotic probe control.
AI & Machine LearningBiotechMedical DevicesRoboticsCampbell, US
Amr Salahieh(Executive Officer, Director, Promoter)Pablo Garcia Kilroy(General Manager)inCasey Gordon(Director)Mariam Maghribi(Executive Officer)David Voris(Executive Officer)
Co-investorsPage One VenturesThe Capital PartnershipUnorthodox Ventures
HealthtechTewksbury, US
Lisa Mastromattei(Executive Officer)Lisa Wipperman Heine(Executive Officer)Sophia Wong(Executive Officer)Richard P. Geoffrion(Executive Officer, Director)
BoardMartien Van Osch(Director)Daniel Cole(Director)
Co-investorsQiming Venture PartnersOxford Bioscience Partners
R3 Vascular develops bioresorbable vascular scaffolds made from a proprietary polymer using a proprietary manufacturing process.
BiotechHealthtechMedical DevicesNew MaterialsMountain View, US
Kamal Ramzipoor(CTO, Founder)inChristopher M. Owens(President and Chief Executive Officer)Mahmood Razavi(Director)JeanMarie Markham(Director)
BoardFrederik Groenewegen(Director)inJohn Springer(Director)
Irvine, US
Tracy Pearson(Executive Officer)Jeffrey J. Valko(Executive Officer, Director)Michael R. Henson(Executive Officer, Director)
Recor Medical develops the Paradise ultrasound renal denervation system, a catheter-based therapy for reducing blood pressure in patients with hypertension.
BiotechHardwareHealthtechMedical DevicesPalo Alto, US
Antoine Papiernik(Executive Officer, Director)F. Thomas Watkins(Director)Kazumichi Kobayashi(Director)Jacques Seguin(Director)Frank Litvack(Director)Martin J. Waters(Executive Officer)
Co-investorsSofinnova Partners
TRiCares develops the Topaz Transfemoral Tricuspid Heart Valve Replacement (TTVR) System, a minimally invasive device for treating tricuspid regurgitation.
BiotechHardwareHealthtechMedical DevicesFrance, FR
Ahmed Elmouelhi(President & CEO)Esther Gerteis(Senior VP Medical & Regulatory Affairs)Michael Litzenburger(VP R&D)
PartnerFrederik Groenewegen· led
Co-investorsEuropean Investment BankAndera PartnersBayern KapitalBioMedPartnersKarista
Endologix develops endovascular medical devices for treating vascular conditions such as abdominal aortic aneurysms and peripheral arterial disease in the femoropopliteal arteries.
HardwareHealthtechMedical Devices
John Liddicoat(President and Chief Executive Officer)Graham Phillips(Chief Operating Officer)Cindy Pinto(Chief Financial Officer)Jorge O'Hara(Chief Commercial Officer)
Co-investorsNew Enterprise Associates (NEA)Deerfield Management Company
Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease.
HealthtechMedical DevicesWayne, US
Bruce J. Shook(President and CEO)Monica Klos(Executive Officer)Neil Hattangadi(Director)Peter Schneider(Director)Mark Garcia(Director)Dennis W. Wahr(Director)
Co-investorsNew Enterprise Associates (NEA)Gilde HealthcareLightstone VenturesVensana Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.